首页> 外文期刊>Nature >Early dissemination seeds metastasis in breast cancer
【24h】

Early dissemination seeds metastasis in breast cancer

机译:乳腺癌的早期传播种子转移

获取原文
获取原文并翻译 | 示例
       

摘要

Accumulating data suggest that metastatic dissemination often occurs early during tumour formation, but the mechanisms of early metastatic spread have not yet been addressed. Here, by studying metastasis in a HER2-driven mouse breast cancer model, we show that progesterone-induced signalling triggers migration of cancer cells from early lesions shortly after HER2 activation, but promotes proliferation in advanced primary tumour cells. The switch from migration to proliferation was regulated by increased HER2 expression and tumour-cell density involving microRNA-mediated progesterone receptor downregulation, and was reversible. Cells from early, low-density lesions displayed more stemness features, migrated more and founded more metastases than cells from dense, advanced tumours. Notably, we found that at least 80% of metastases were derived from early disseminated cancer cells. Karyotypic and phenotypic analysis of human disseminated cancer cells and primary tumours corroborated the relevance of these findings for human metastatic dissemination.
机译:越来越多的数据表明,转移扩散通常发生在肿瘤形成的早期,但是早期转移扩散的机制尚未得到解决。在这里,通过研究HER2驱动的小鼠乳腺癌模型中的转移,我们显示孕酮诱导的信号传导在HER2激活后不久触发癌细胞从早期病变的迁移,但促进晚期原发性肿瘤细胞的增殖。从迁移到增殖的转换受HER2表达增加和涉及microRNA介导的孕激素受体下调的肿瘤细胞密度的调节,并且是可逆的。与来自密集,晚期肿瘤的细胞相比,来自早期低密度病变的细胞显示出更多的干性特征,更多的迁移并形成了更多的转移灶。值得注意的是,我们发现至少80%的转移灶来自早期扩散的癌细胞。人类弥散性癌细胞和原发性肿瘤的核型和表型分析证实了这些发现与人类转移性传播的相关性。

著录项

  • 来源
    《Nature》 |2016年第7634期|552-558|共7页
  • 作者单位

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany|Univ Basel, Univ Basel Hosp, Dept Biomed, Tumor Heterogene Metastasis & Resistance, CH-4031 Basel, Switzerland;

    Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany;

    Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Dept Med, Dept Otolaryngol,Dept Oncol Sci,Tisch Canc Inst,B, New York, NY 10029 USA;

    Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Dept Med, Dept Otolaryngol,Dept Oncol Sci,Tisch Canc Inst,B, New York, NY 10029 USA|Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pharmacol Sci, One Gustave L Levy Pl, New York, NY 10029 USA;

    Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany|Tech Univ Dresden, Dept Gastrointestinal Thorac & Vasc Surg, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany;

    Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany;

    Univ Regensburg, Inst Funct Genom, Dept Stat Bioinformat, D-93053 Regensburg, Germany;

    Univ Regensburg, Biochem Ctr Regensburg BZR, Lab RNA Biol, D-93053 Regensburg, Germany;

    Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany;

    Univ Tubingen, Dept Gynecol & Obstet, D-72076 Tubingen, Germany;

    Univ Tubingen, Dept Gynecol & Obstet, D-72076 Tubingen, Germany;

    Univ Tubingen, Dept Gynecol & Obstet, D-72076 Tubingen, Germany;

    Univ Dusseldorf, Dept Gynecol & Obstet, D-40225 Dusseldorf, Germany;

    Univ Munich, Dept Gynecol & Obstet, D-80337 Munich, Germany;

    Univ Med Ctr Regensburg, Dept Gynecol & Obstet, D-93053 Regensburg, Germany;

    Univ Regensburg, Inst Funct Genom, Dept Stat Bioinformat, D-93053 Regensburg, Germany;

    Univ Regensburg, Biochem Ctr Regensburg BZR, Lab RNA Biol, D-93053 Regensburg, Germany;

    Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Dept Med, Dept Otolaryngol,Dept Oncol Sci,Tisch Canc Inst,B, New York, NY 10029 USA;

    Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany|Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:52:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号